MoneyWorks4Me

Mercury Laboratories - Quaterly Results

21 Oct 2021 Evaluate
The sales is pegged at Rs. 134.73 millions for the September 2021 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 189.10 millions during the year-ago period.A big decline of -41.75% was reported for the quarter ended September 2021 to Rs. 9.64  millions from Rs. 16.55 millions of corresponding previous quarter.A decline of 22.56 millions was observed in the OP in the quarter ended September 2021 from 30.87 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 134.73 189.10 -28.75 289.96 322.64 -10.13 686.02 572.69 19.79
Other Income 2.35 3.60 -34.72 3.64 3.91 -6.91 8.80 8.50 3.53
PBIDT 22.56 30.87 -26.92 46.68 50.14 -6.90 104.72 70.16 49.26
Interest 1.43 2.73 -47.62 2.53 3.96 -36.11 6.41 8.18 -21.64
PBDT 21.13 28.14 -24.91 44.15 46.18 -4.40 98.31 61.98 58.62
Depreciation 7.03 5.19 35.45 12.13 9.66 25.57 19.21 18.69 2.78
PBT 14.10 22.95 -38.56 32.02 36.52 -12.32 79.10 43.29 82.72
TAX 4.46 6.40 -30.31 9.92 10.37 -4.34 25.72 11.01 133.61
Deferred Tax 0.55 0.86 -36.05 1.17 2.41 -51.45 3.88 -0.82 -573.17
PAT 9.64 16.55 -41.75 22.10 26.15 -15.49 53.38 32.28 65.37
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 16.74 16.32 2.57 16.10 15.54 3.59 15.26 12.25 24.60
Peers
Company Name CMP
Sun Pharma. Inds. 1840.55
Dr. Reddys Labs. 1245.45
Cipla 1387.80
Lupin 2075.00
Zydus Lifesciences 1212.35
View more..